Neem Biotech Overview

  • Founded
  • 1998
Founded
  • Status
  • Acquired/​Merged
  • Latest Deal Type
  • M&A
  • Financing Rounds
  • 1
  • Investments
  • 1

Neem Biotech General Information

Description

Developer of pharmaceutical products intended for the treatment of human, animal and plant infections. The company's pharmaceutical products include anti-infectives and antimicrobial products that are produced from marine and plant sources, enabling the treatment of human, animal and plant infections in areas of high unmet medical need and rare diseases.

Contact Information

Ownership Status
Acquired/Merged
(Operating Subsidiary)
Financing Status
Corporate Backed or Acquired
Primary Industry
Drug Discovery
Parent Company
InQpharm Group
Primary Office
  • Units G+H Roseheyworth Business Park
  • Blaenau Gwent
  • Abertillery NP13 1SX
  • Wales, United Kingdom
+44 01495 000000
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Neem Biotech Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Neem Biotech‘s full profile, request access.

Request a free trial

Neem Biotech Executive Team (5)

Name Title Board Seat Contact Info
Graham Dixon Head, Research & Development & Managing Director
Phil Dudfield Chief Scientific Officer
Thomas Hafner Executive Chairman
You’re viewing 3 of 5 executive team members. Get the full list »

Neem Biotech Board Members (2)

Name Representing Role Since
000000 000000 Self Executive Chairman 000 0000
You’re viewing 1 of 2 board members. Get the full list »

Neem Biotech Investments (1)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
00000000 000000000 000000000 Drug Discovery
To view Neem Biotech’s complete investments history, request access »